Table 1.
Gender-stratified characteristics of MetS patients and healthy control subjects
| |
Men |
Women |
Total |
|||
|---|---|---|---|---|---|---|
| Control (n = 11) | MetS (n = 15) | Control (n = 15) | MetS (n = 15) | Control (n = 26) | MetS (n = 30) | |
| Age (years) |
41.2 ± 9.8 |
48.9 ± 7.1* |
49.3 ± 15.7 |
53.2 ± 4.4 |
45.9 ± 13.9 |
51.1 ± 6.2* |
| Waist (cm) |
88.5 ± 10.6 |
106.4 ± 12.9** |
74.4 ± 8.0
#
|
106.2 ± 15.2** |
80.4 ± 11.5 |
106.3 ± 13.9** |
| SBP (mmHg) |
121.3 ± 9.6 |
136.2 ± 16.5* |
120.1 ± 26.8 |
120.2 ± 14.8 |
120.6 ± 21.0 |
127.5 ± 17.3 |
| DBP (mmHg) |
81.5 ± 10.2 |
83.4 ± 9.8 |
73.0 ± 14.6 |
74.5 ± 9.6 |
76.6 ± 13.4 |
78.6 ± 10.5 |
| Glucose (mg/dL) |
89.2 ± 7.7 |
142.7 ± 59.1** |
85.1 ± 7.4 |
102.4 ± 19.4** |
86.9 ± 7.6 |
122.5 ± 47.8** |
| TC (mg/dL) |
232.0 ± 47.8 |
196.9 ± 48.0 |
224.9 ± 60.0 |
220.0 ± 59.1 |
227.9 ± 54.2 |
208.5 ± 54.2 |
| TG (mg/dL) |
151.8 ± 95.0 |
180.9 ± 151.8 |
106.3 ± 95.5 |
144.1 ± 59.0* |
125.6 ± 96.2 |
162.5 ± 114.7 |
| HDL-C (mg/dL) |
52.7 ± 15.8 |
44.0 ± 12.2 |
62.1 ± 13.7 |
54.0 ± 19.2 |
58.1 ± 15.1 |
49.0 ± 16.6* |
| LDL-C (mg/dL) |
149.0 ± 37.9 |
120.9 ± 45.3 |
142.3 ± 52.1 |
143.9 ± 41.2 |
145.2 ± 45.9 |
132.8 ± 44.0 |
| L5 (%) | 4.1 ± 5.3 | 16.9 ± 14.6** | 5.1 ± 5.6 | 10.1 ± 8.5* | 4.7 ± 5.4 | 13.5 ± 12.2** |
Values represent the mean ± standard deviation. P-values were determined by using the Wilcoxon rank sum test (Mann–Whitney U test). MetS metabolic syndrome; SBP systolic blood pressure; DBP diastolic blood pressure; TC total cholesterol; TG triglyceride; HDL-C HDL cholesterol; LDL-C LDL cholesterol. *P < 0.05, **P < 0.01 vs gender-matched control group; # P < 0.05 vs male control group.